EODData

FRA, 8E8: ELICERA THERAPEUTICS AB

18 Aug 2026
LAST:

0.2190

CHANGE:
 0.01
OPEN:
0.2190
HIGH:
0.2190
ASK:
0.0000
VOLUME:
0
CHG(%):
4.99
PREV:
0.2305
LOW:
0.2190
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
18 Aug 260.21900.21900.21900.21900
17 Aug 260.23050.23050.23050.23050
14 Aug 260.23700.23700.23700.23700
13 Aug 260.23800.23800.23800.23800
12 Aug 260.23800.23800.23800.23800
07 Aug 260.18760.18760.18760.18760
06 Aug 260.18260.18260.18260.18260
05 Aug 260.18400.18400.18400.18400
04 Aug 260.18160.18160.18160.18160
03 Aug 260.18800.18800.18800.18800

PROFILE

Name:ELICERA THERAPEUTICS AB
About:Elicera Therapeutics AB (publ), a clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden. The company's portfolio products in pipeline includes ELC-100 that is in Phase I/IIa clinical trial for neuroendocrine tumors; and ELC-201, which is in preclinical stage for the treatment of various forms of solid cancer. It is also developing ELC-301, a CAR T-cell therapy that is in Phase I/IIa clinical trial for the treatment of Non-Hodgkin's B-cell lymphoma; and ELC-401, a CAR T-cell therapy, which is in preclinical stage for the treatment of brain tumors. Elicera Therapeutics AB (publ) has collaboration with the Vecura R&D division at Karolinska University Hospital and Uppsala University to develop a fully automated production flow of ELC-401 for use in future clinical trials. The company was incorporated in 2014 and is based in Gothenburg, Sweden.
Sector:Healthcare
Industry:Biotechnology
Address:World Trade Center Göteborg, Gothenburg, Sweden, 412 51
Website:https://www.elicera.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-0.61 
PEG Ratio:0.01 
Price to Sales:4.62 
Price to Book:0.36 
Profit Margin:-1.36 
Operating Margin:-1.07 
Return on Assets:-0.28 
Return on Equity:-0.57 
Revenue:546.9K 
Shares:48.54M 
Market Cap:10.63M 

TECHNICAL INDICATORS

MA5:0.236.2%
MA10:0.215.0%
MA20:0.207.7%
MA50:0.213.4%
MA100:0.2930.5%
MA200:0.3978.8%
STO9:66.31
STO14:68.01
RSI14:56.52
WPR14:-31.99
MTM14:0.03
ROC14:0.17 
ATR:0.01 
Week High:0.248.7%
Week Low:0.220.0%
Month High:0.248.7%
Month Low:0.1878.8%
Year High:0.69212.8%
Year Low:0.1822.6%
Volatility:33.88